Delivery Order SPE2DB24D2003-SPE2DB25FXMV2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Norethindrone 5 mg tablets (90-count units) with a contract ceiling value of $6,039.97. This competitively awarded, non-set-aside delivery order represents a firm fixed price transaction with an ultimate completion date of September 5, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a $1,404.76 delivery order to AmerisourceBergen Drug Corp for the supply of Estradiol-Norethindrone 0.5-0.1 mg tablets (28-count units), with an ultimate completion date of April 23, 2025. This is a firm fixed-price, non-set-aside contract executed on April 22, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Norgestimate-EE 0.25-0.035 mg contraceptive medication in a 28-day supply. This competitive, non-set-aside delivery order carries a ceiling value of $3,290.16 under firm fixed price terms, with an ultimate completion date of September 11, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 25, 2025, for the supply of Norethindrone 5 mg tablets (90-count units). This firm fixed-price delivery order, valued at $2,643.64, represents a non-competitive set-aside award and is scheduled for completion by June 26, 2025. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,217.22 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Norgestimate-EE 0.25-0.035 mg in a 28-tablet package. This non-set-aside, firm fixed price delivery order was competitively awarded and is scheduled for completion by August 28, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's broader federal...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,354.10, is for the supply of 4567648997 NORETHINDRONE 5 MG TABLET 50S. It is a Firm Fixed Price contract with a performance period through March 24, 2025. The contract was not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency Medical Supply Chain awarded a $3,385.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Norethindrone 5mg, with an ultimate completion date of August 27, 2025. This non-set-aside competitive award represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and...
- The Defense Logistics Agency awarded a $3,237.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Norgestimate-EE 0.25-0.035 mg 28-tablet pack pharmaceutical supplies. The contract was awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award issued under a larger indefinite delivery contract vehicle. This...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of pharmaceutical products including norethindrone-ethinyl estradiol tablets. The potential value of the contract is $1,114.24, and the performance location is Amerisourcebergen's corporate headquarters in Conshohocken, Pennsylvania. The contract is not designated as a set-aside and has a completion date of January...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,964.90 firm fixed-price delivery order is for the supply of 4567050123 NORETHINDRONE 5 MG TABLET 90S, with a performance period through January 28, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXMV2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Norethindrone-Ethinyl Estradiol 0.5-2.5mg tablets (28-count package), with a contract ceiling value of $1,232.93. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract is scheduled for completion by September 17, 2025, with performance to occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a small-value pharmaceutical transaction typical of the company's routine federal medical supply operations. This award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen serves as a prime pharmaceutical vendor supplying the Defense Health Agency and other military healthcare systems with a comprehensive range of pharmaceuticals, vaccines, and medical supplies. The company's role as a critical vendor in the federal medical supply chain reflects its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains in support of military and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/16/25 |